European Leukemia Trial Registry
Trial: GS-US-339-1560

More Details
Title Phase I-Studie mit Entospletinib in Kombination mit Vincristin und Dexamethason bei rezidivierter/refraktärer ALL
Scientific Title A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) With Vincristine and Dexamethasone in Adult Subjects With Relapsed or Refractory Acute Lymphoid Leukemia (ALL)
Short Title GS-US-339-1560
Trialgroup NN
Type of Trial multicentric, single-group, prospective, open-label
Disease Acute lymphoblastic leukemia(ALL) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 01.10.2016
Leader Gökbuget, Dr. med., Nicola
Shortprotocol Shortprotocol
created 04.10.2016 Eva-Maria Ableidinger
changed 03.05.2018 Student Studienregister
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org